(Q39544983)

12 September 2017

title

Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma (English)

1 reference

12 September 2017

Kikuchi E

1

1 reference

12 September 2017

Nakashima J

2

1 reference

12 September 2017

Ishibashi M

3

1 reference

12 September 2017

Ohigashi T

4

1 reference

12 September 2017

Asakura H

5

1 reference

12 September 2017

Tachibana M

6

1 reference

12 September 2017

Murai M

7

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

12 September 2017

1 reference

12 September 2017

volume

89

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

842-849

1 reference

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Prostate specific antigen adjusted for the transition zone volume as an indicator of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Volume determinations of the whole prostate and of adenomas by transrectal ultrasound in patients with clinically benign prostatic hyperplasia: correlation of resected weight, blood loss and duration of operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Effect of Inflammation and Benign Prostatic Hyperplasia on Elevated Serum Prostate Specific Antigen Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Rate of Change in Serum Prostate Specific Antigen Levels as a Method For Prostate Cancer Detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Development of an immunoassay specific for the PSA-ACT complex without the problem of high background

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Correlation of serum concentrations of PSA-ACT complex with total PSA in random and serial specimens from patients with BPH and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Prostate-specific antigen and prostate gland volume: Correlation and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000815%2989%3A4%3C842%3A%3AAID-CNCR17%3E3.0.CO%3B2-9

10.1002/1097-0142(20000815)89:4<842::AID-CNCR17>3.0.CO;2-9

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference